Skip to content
Catalyst

Psoriasis Area and Severity Index (PASI) scorePapers

Measures Psoriasis Area and Severity Index (PASI) score as an outcome

papers
3
3 years, by papers

Newest first

1 to 3 of 3
  • Efficacy and safety of topical rosuvastatin & melatonin vs. placebo in patients with mild to moderate plaque psoriasis: A preliminary randomized double-blinded clinical trial.

    Skin research and technology2024PMID 38563131

  • Effects of fish oil supplement on psoriasis: a meta-analysis of randomized controlled trials.

    BMC complementary and alternative medicine2019PMID 31805911

  • Oral fumaric acid esters for psoriasis: abridged Cochrane systematic review including GRADE assessments.

    The British journal of dermatology2016PMID 27087044

Every paper about Psoriasis Area and Severity Index (PASI) score